Anthony Patrick McHale

Title: Innovations by Anthony Patrick McHale

Introduction

Anthony Patrick McHale is a notable inventor based in Ballycastle, GB. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of three patents to his name, McHale's work focuses on advanced therapeutic methods that aim to improve patient outcomes.

Latest Patents

One of McHale's latest patents is the "Sensitizer-peptide conjugate." This invention relates to a sensitizer-peptide conjugate designed for use in the treatment of cancer, particularly melanoma. The invention also discusses the application of this conjugate in photodynamic therapy or sonodynamic therapy. The sensitizer-peptide conjugate comprises at least one sensitizer and at least one peptide, showcasing a novel approach to cancer treatment.

Another significant patent is the "Microbubble-chemotherapeutic agent complex for sonodynamic therapy." This invention outlines methods of sonodynamic therapy that involve the co-administration of a microbubble-chemotherapeutic agent complex alongside a microbubble-sonosensitizer complex. It also includes pharmaceutical compositions that utilize these complexes for cancer treatment, specifically targeting pancreatic cancer.

Career Highlights

Anthony Patrick McHale is affiliated with the University of Ulster, where he continues to engage in research and development in the field of cancer therapies. His work has garnered attention for its potential to enhance treatment efficacy and patient care.

Collaborations

Some of McHale's notable coworkers include John Francis Callan and Eleanor Stride. Their collaborative efforts contribute to the advancement of innovative solutions in cancer treatment.

Conclusion

Anthony Patrick McHale's contributions to cancer treatment through his patents reflect his commitment to innovation in medical science. His work continues to pave the way for new therapeutic approaches that may significantly impact patient care.